JPS5758614A - Injectable drug composition - Google Patents

Injectable drug composition

Info

Publication number
JPS5758614A
JPS5758614A JP56121757A JP12175781A JPS5758614A JP S5758614 A JPS5758614 A JP S5758614A JP 56121757 A JP56121757 A JP 56121757A JP 12175781 A JP12175781 A JP 12175781A JP S5758614 A JPS5758614 A JP S5758614A
Authority
JP
Japan
Prior art keywords
drug composition
injectable drug
injectable
composition
drug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP56121757A
Other languages
English (en)
Inventor
Barianto Moorudeingu Hookinsu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of JPS5758614A publication Critical patent/JPS5758614A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP56121757A 1980-08-04 1981-08-03 Injectable drug composition Pending JPS5758614A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/174,817 US4297353A (en) 1980-08-04 1980-08-04 Non-irritating injectable dosage forms

Publications (1)

Publication Number Publication Date
JPS5758614A true JPS5758614A (en) 1982-04-08

Family

ID=22637640

Family Applications (1)

Application Number Title Priority Date Filing Date
JP56121757A Pending JPS5758614A (en) 1980-08-04 1981-08-03 Injectable drug composition

Country Status (16)

Country Link
US (1) US4297353A (ja)
JP (1) JPS5758614A (ja)
AU (1) AU7318381A (ja)
BE (1) BE889785A (ja)
DE (1) DE3128579A1 (ja)
DK (1) DK345681A (ja)
ES (1) ES8401721A1 (ja)
FI (1) FI812369L (ja)
FR (1) FR2487675A1 (ja)
GB (1) GB2087232A (ja)
IL (1) IL63486A0 (ja)
IT (1) IT1171422B (ja)
NL (1) NL8103626A (ja)
PT (1) PT73466B (ja)
SE (1) SE8104657L (ja)
ZA (1) ZA815356B (ja)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4746515A (en) * 1987-02-26 1988-05-24 Alza Corporation Skin permeation enhancer compositions using glycerol monolaurate
SI9300468A (en) * 1992-10-14 1994-06-30 Hoffmann La Roche Injectable composition for the sustained release of biologically active compounds
US7829100B2 (en) * 2000-09-12 2010-11-09 Teagarden Dirk L Pharmaceutical composition having modified carrier
US6960346B2 (en) * 2002-05-09 2005-11-01 University Of Tennessee Research Foundation Vehicles for delivery of biologically active substances
US7659061B2 (en) * 2002-11-19 2010-02-09 Pharmacia & Upjohn Company Pharmaceutical compositions having a modified vehicle

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3194733A (en) * 1961-04-26 1965-07-13 Olin Mathicson Chemical Corp Phenothiazine compositions and method of treating mental disorders

Also Published As

Publication number Publication date
PT73466B (en) 1983-02-08
BE889785A (fr) 1982-01-29
DK345681A (da) 1982-02-05
IT1171422B (it) 1987-06-10
DE3128579A1 (de) 1982-08-19
IL63486A0 (en) 1981-11-30
AU7318381A (en) 1982-03-11
PT73466A (en) 1981-09-01
FI812369L (fi) 1982-02-05
NL8103626A (nl) 1982-03-01
GB2087232A (en) 1982-05-26
ES504517A0 (es) 1983-05-01
ES8401721A1 (es) 1983-05-01
US4297353A (en) 1981-10-27
IT8149006A0 (it) 1981-07-29
SE8104657L (sv) 1982-02-05
FR2487675A1 (fr) 1982-02-05
ZA815356B (en) 1983-03-30

Similar Documents

Publication Publication Date Title
ZA813465B (en) Pharmaceutical composition
GB2083755B (en) Syringe
IL63508A0 (en) Self-destructible syringes
ZA817988B (en) Non-yellowing pharmaceutical composition
DE3164692D1 (en) Ultraviolet-transmissible composition
JPS5740518A (en) Self-oxidizable composition
EP0093551A3 (en) Pharmaceutical composition
GB2084662B (en) Syringe
ZA81136B (en) Pharmaceutical compositions
JPS5793907A (en) Locally administratable pharmaceutical composition
JPS57103639A (en) Non-refilling type syringe
JPS56139420A (en) Drug
GB2072504B (en) Pharmaceutical compositions
ZA815700B (en) Pharmaceutical compositions
JPS5758614A (en) Injectable drug composition
JPS573839A (en) Composition
DE3176849D1 (en) Pharmaceutical composition comprising 4-carbamoyl-imidazolium-5-olate
EP0051789A3 (en) Therapeutic composition
MTP884B (en) Pharmaceutical preparationes
PT73952A (en) Pharmaceutical compositions
JPS5527168A (en) Drug composition
JPS56108780A (en) Prostanid compound*its manufacture and drug composition
ZA814056B (en) Pharmaceutical bicyclo-octatriene compounds and compositions
ZA813632B (en) Ampoule
ZA815175B (en) Pharmaceutical composition